20 articles
New research shows integrated HBV DNA — not active viral replication — is the dominant source of surface antigen in HBeAg-negative chronic hepatitis B.
Comprehensive molecular analysis reveals complex host-microbiome interactions driving gastric cancer development and progression.
A 12-week trial tested whether a bioactive hydrolysate could reduce gut discomfort, inflammation, and blood sugar issues in healthy elderly participants.
A 13-year UK analysis of 273 liver transplant patients finds HBIG maintenance may be unnecessary, with NA-only prophylaxis offering a cost-effective alternative.
New research shows blocking PKM2 in immune cells promotes gut healing in colitis while preventing tumor formation.
Scientists discover friendly gut bacteria use injection systems to send proteins into human cells, influencing immunity and inflammation.
Researchers develop innovative fluorescent approach to combat chronic hepatitis E, offering new hope for treatment-resistant infections.
A modular bioelectronic sensing system uses engineered bacterial co-cultures to detect metals, molecules, and peptides across diverse real-world environments.
A microbial enzyme from Bifidobacterium enhances anti-TNF therapy efficacy in IBD by reshaping immune regulation via histone lactylation.
A fetal enzyme floods newborns with hyocholic acids that train immune tolerance and shape a healthy gut microbiome—then disappear by adulthood.
Scientists develop scBPS tool to identify which human cells interact with specific gut microbes, revealing new therapeutic targets.
P. gingivalis bacteria secretes proteins that transform healthy cells into cancer-like cells, revealing new gut-cancer connections.
Scientists identify bacterial signature that predicts cancer recurrence, potentially enabling personalized monitoring strategies.
Study reveals how IL-6 inflammation protein fuels liver cancer growth and identifies potential therapeutic vulnerability.
Engineered cerium-peptide microspheres show 76% reduction in IBD symptoms and 66% decrease in fibrosis markers in mouse studies.
New research questions whether long-term HBIG therapy is necessary after liver transplantation, potentially simplifying post-transplant care.
New review reveals how gut microbe chemicals directly reprogram tumor immune responses through multiple pathways.
New research shows how a specific gut bacteria enhances anti-PD-1 therapy effectiveness in hard-to-treat colorectal cancers.
New research in Cell Metabolism explores how gut bacteria and their metabolites regulate immune checkpoint blockade efficacy in cancer patients.
Scientists discover how intestinal cells starve harmful Candida fungi of essential zinc to prevent colonization and overgrowth.
